A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation.
Gene variant discovery is becoming routine, but it remains difficult to usefully interpret the functional consequence or disease relevance of most variants. To fill this interpretation gap, experimental assays of variant function are becoming common place. Yet, it remains challenging to make these a...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-09-01
|
Series: | PLoS Genetics |
Online Access: | https://doi.org/10.1371/journal.pgen.1009774 |
_version_ | 1831715307300847616 |
---|---|
author | Payel Ganguly Landiso Madonsela Jesse T Chao Christopher J R Loewen Timothy P O'Connor Esther M Verheyen Douglas W Allan |
author_facet | Payel Ganguly Landiso Madonsela Jesse T Chao Christopher J R Loewen Timothy P O'Connor Esther M Verheyen Douglas W Allan |
author_sort | Payel Ganguly |
collection | DOAJ |
description | Gene variant discovery is becoming routine, but it remains difficult to usefully interpret the functional consequence or disease relevance of most variants. To fill this interpretation gap, experimental assays of variant function are becoming common place. Yet, it remains challenging to make these assays reproducible, scalable to high numbers of variants, and capable of assessing defined gene-disease mechanism for clinical interpretation aligned to the ClinGen Sequence Variant Interpretation (SVI) Working Group guidelines for 'well-established assays'. Drosophila melanogaster offers great potential as an assay platform, but was untested for high numbers of human variants adherent to these guidelines. Here, we wished to test the utility of Drosophila as a platform for scalable well-established assays. We took a genetic interaction approach to test the function of ~100 human PTEN variants in cancer-relevant suppression of PI3K/AKT signaling in cellular growth and proliferation. We validated the assay using biochemically characterized PTEN mutants as well as 23 total known pathogenic and benign PTEN variants, all of which the assay correctly assigned into predicted functional categories. Additionally, function calls for these variants correlated very well with our recent published data from a human cell line. Finally, using these pathogenic and benign variants to calibrate the assay, we could set readout thresholds for clinical interpretation of the pathogenicity of 70 other PTEN variants. Overall, we demonstrate that Drosophila offers a powerful assay platform for clinical variant interpretation, that can be used in conjunction with other well-established assays, to increase confidence in the accurate assessment of variant function and pathogenicity. |
first_indexed | 2024-12-21T00:16:39Z |
format | Article |
id | doaj.art-5cb487758be84e0eb6cf26744bfaff89 |
institution | Directory Open Access Journal |
issn | 1553-7390 1553-7404 |
language | English |
last_indexed | 2024-12-21T00:16:39Z |
publishDate | 2021-09-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS Genetics |
spelling | doaj.art-5cb487758be84e0eb6cf26744bfaff892022-12-21T19:22:13ZengPublic Library of Science (PLoS)PLoS Genetics1553-73901553-74042021-09-01179e100977410.1371/journal.pgen.1009774A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation.Payel GangulyLandiso MadonselaJesse T ChaoChristopher J R LoewenTimothy P O'ConnorEsther M VerheyenDouglas W AllanGene variant discovery is becoming routine, but it remains difficult to usefully interpret the functional consequence or disease relevance of most variants. To fill this interpretation gap, experimental assays of variant function are becoming common place. Yet, it remains challenging to make these assays reproducible, scalable to high numbers of variants, and capable of assessing defined gene-disease mechanism for clinical interpretation aligned to the ClinGen Sequence Variant Interpretation (SVI) Working Group guidelines for 'well-established assays'. Drosophila melanogaster offers great potential as an assay platform, but was untested for high numbers of human variants adherent to these guidelines. Here, we wished to test the utility of Drosophila as a platform for scalable well-established assays. We took a genetic interaction approach to test the function of ~100 human PTEN variants in cancer-relevant suppression of PI3K/AKT signaling in cellular growth and proliferation. We validated the assay using biochemically characterized PTEN mutants as well as 23 total known pathogenic and benign PTEN variants, all of which the assay correctly assigned into predicted functional categories. Additionally, function calls for these variants correlated very well with our recent published data from a human cell line. Finally, using these pathogenic and benign variants to calibrate the assay, we could set readout thresholds for clinical interpretation of the pathogenicity of 70 other PTEN variants. Overall, we demonstrate that Drosophila offers a powerful assay platform for clinical variant interpretation, that can be used in conjunction with other well-established assays, to increase confidence in the accurate assessment of variant function and pathogenicity.https://doi.org/10.1371/journal.pgen.1009774 |
spellingShingle | Payel Ganguly Landiso Madonsela Jesse T Chao Christopher J R Loewen Timothy P O'Connor Esther M Verheyen Douglas W Allan A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation. PLoS Genetics |
title | A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation. |
title_full | A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation. |
title_fullStr | A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation. |
title_full_unstemmed | A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation. |
title_short | A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation. |
title_sort | scalable drosophila assay for clinical interpretation of human pten variants in suppression of pi3k akt induced cellular proliferation |
url | https://doi.org/10.1371/journal.pgen.1009774 |
work_keys_str_mv | AT payelganguly ascalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT landisomadonsela ascalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT jessetchao ascalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT christopherjrloewen ascalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT timothypoconnor ascalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT esthermverheyen ascalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT douglaswallan ascalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT payelganguly scalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT landisomadonsela scalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT jessetchao scalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT christopherjrloewen scalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT timothypoconnor scalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT esthermverheyen scalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT douglaswallan scalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation |